Korsana Biosciences, Inc. (KRSA)

US · Healthcare · Biotechnology

$33.72+7.97%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Net profit

$-1.8M

EPS

$-2.89

Market cap

$10.11B

Forward P/E

0.0

P/B

0.00

EPS (TTM)

$-0.11

52-week high

$59.36

52-week low

$7.19

50-day MA

$26.78

200-day MA

$18.40

with an average price target of $49.00.

Insiders

0.38%

Institutions

21.03%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Korsana Biosciences, Inc. — free to start.

Data updated 2026-09-18.